期刊文献+

北京协和医院1990—2009年住院患者尿道感染常见病原菌及其耐药性 被引量:5

Pathogens and Antibiotic Resistance of Isolates from Patients with Urinary Tract Infections in Peking Union Medical College Hospital,1990-2009
下载PDF
导出
摘要 目的了解住院患者尿道细菌感染常见病原菌及其对抗菌药物的耐药性。方法用纸片扩散法对1990-2009年北京协和医院住院患者尿道感染分离的4565株病原菌进行抗菌药物耐药监测。结果 20年来北京协和医院住院患者尿道感染以大肠埃希菌检出率最高(33%),其次为粪肠球菌(12%)、屎肠球菌(8%)、凝固酶阴性葡萄球菌(7%)、铜绿假单胞菌(6%)和肺炎克雷伯菌(6%)。2006-2009年产超广谱β-内酰胺酶(extended-spectrum beta-lac-tamases,ESBLs)的大肠埃希菌检出率为60%;大肠埃希菌对亚胺培南、美罗培南和厄他培南均100%敏感,对环丙沙星和左氧氟沙星的耐药率为77.7%和76.4%。粪肠球菌对呋喃妥因和磷霉素的耐药率均低于10%。结论住院患者尿道感染最常见的病原菌是大肠埃希菌,且细菌耐药性呈增长趋势,临床上应加强细菌耐药监测。 Objective To identify the common pathogens of urinary tract infections and the potential existence of drug resistance. Methods A total of 4565 clinical isolates from patients with urinary tract infections were collected in Peking Union Medical College Hospital from 1990 to 2009. Antimicrobial susceptibility was detected by disk diffusion method. Results The most common pathogen identified was E. coli (33%), followed by Enterococcus faecalis (12%), Enterococcus faecium (8%), coagulase negative staphylococcus (7 % ), Pseudomonas aeruginosa (6%), and Klebsiella pneumoniae (6%). Extended-spectrum betalactamases (ESBLs) -producing strains in E. coli isolate was 60% from 2006 to 2009. Strains of E. coli and K. pneumoniae were still highly susceptible to imipenem, meropenem, and ertapenem. The resistance rates of E. coli strains to ciprofloxacin and levofloxacin were 77.7% and 76.4% , respectively. The resistance rates of E. faecalis to nitrofurantoin and fosfomycin were lower than 10%. Conclusion E. coli is the main cause of urinary tract infection. Bacterial resistance remains a major concern and more efforts should be made in the monitoring of drug resistance.
出处 《协和医学杂志》 2010年第1期87-90,共4页 Medical Journal of Peking Union Medical College Hospital
关键词 尿道感染 病原菌 细菌耐药性 urinary tract infection pathogenic bacterium bacterial resistance
  • 相关文献

参考文献10

  • 1Performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute(CLSI)M100-S20 . 2010
  • 2Stamm WE,Norrby RS.Urinary tract infections:disease panorama and challenges. The Journal of Infectious Diseases . 2001
  • 3WHO.Epidemiology of nosocomial infections. Prevention of hospital acquired infections:a practical guide . 2002
  • 4Matsumoto T,Muratani T.Newer carbapenems for urinary tract infections. International Journal of Antimicrobial Agents . 2004
  • 5Nordmann P,,Poirel L.Emergence of plasmid-mediated re-sistance to quinolones in Enterobacteriaceae. Journal of Antimicrobial Chemotherapy . 2005
  • 6Lautenbach E,Fishman NO,Bilker WB,etal.Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Archives of Internal Medicine . 2002
  • 7Olson RP,Harrell LJ,Kaye KS.Antibiotic resistance in u-rinary isolates of Escherichia coli fromcollege women with u-rinary tract infections. Antimicrobial Agents and Chemotherapy . 2009
  • 8Javiya VA,Ghatak SB,Patel KR,et al.Antibiotic suscep-tibility patterns ofPseudomonas aeruginosaat a tertiary care hospital in Gujarat. Indian Journal of Pharmaceutical Sciences . 2008
  • 9Thean YT,SiewYN,Wan XN.Clinical significance of co-agulase-negative staphylococci recovered from nonsterile sites. Journal of Clinical Microbiology . 2006
  • 10Piddock L J.Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs . 1999

同被引文献43

  • 1谢志祥.尿路感染病原菌的分布及耐药性分析[J].中华医院感染学杂志,2004,14(4):471-472. 被引量:51
  • 2Rupasinghe HPV, Boulter-Bitzer J, Ahn T, et al. Vanillin in- hibits pathogenic and spoilage microorganisms in vitro and aerobic microbial growth in fresh-cut apples [J~. Food research internation- al, 2006, 39 (5): 575-580.
  • 3Woelk CH, Zhang JX, Walls L, et al. Factors regulated by inter- feron gamma and hypoxia-inducible factor 1A contribute to respons- es that protect mice from Coccidioides immitis infection [J]. BMC Microbiol, 2012, 12 (1): 218.
  • 4Matouek J, Stehlk J, Proch6zkovt J, et al. Biological and molecular analysis of the pathogenic variant C3 of potato spindle tu- ber viroid (PSTVd) evolved during adaptation to chamomile (Ma- tricariachamomilla)[J]. Biol Chem, 2012, 393 (7): 605-615.
  • 5CLSI. Performance standards for antimicrobial susceptibility Tes- ting( Twentieth Informational Supplement) [ S ]. Wayne, PA:Clinical and Laboratory Standards Institute, 2010 : MIO0 - $20.
  • 6Clinical and Laboratory Standards Institute. Performancestandards for antimicrobial susceptibility Testing( TwentiethInformational Supplement)[S]. M100-S20. CLSI’2010.
  • 7汪复,张婴元.实用抗感染治疗学[M].北京:人民卫生出版社,2012:238.
  • 8Zhang J, Xu J F, Liu Y B, et al. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower re- spiratory tract infections: results of a prospective multicenter study in China[J]. J Infect Chemother, 2009, 15(5) : 293 - 300.
  • 9Cao G, Zhang J, Wu X, et al. Pharmacokinetics and pharmacodynamicsof levofloxacin injection in healthy Chinese volunteers and dosing regi- men optimization[J]. J Clin Pharm Ther, 2013, 38(5) : 394 -400.
  • 10Capitano B, Matloes H M, Shore E, et al. Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults[J]. Chest, 2004, 125(3) : 965 -973.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部